Recent arrests in the UK shed some light on the British British counter terrorism tools and strategies. We talk about intelligence gathering system and how it compares to our own.


  • Paul Wilkinson professor, international relations, chair of the advisory board at the Centre for Study of Terrorism and Political Violence,University of Saint Andrews, and author of "Terrorism and Democracy"
  • Juliette Kayyem lecturer, public policy, Harvard University's Kennedy School of Government and co-author of "Protecting Liberty in an Age of Terror"
  • David Rivkin attorney in private practice and former Justice Department official during the Reagan and George H.W. Bush administrations. Worked in the Office of the Vice President for Dan Quayle.


comments powered by Disqus
Most Recent Shows

Friday News Roundup – International

Friday, Oct 02 2015Russia launches another round of airstrikes in Syria. In Afghanistan, fighting with the Taliban continues in Kunduz. And a Palestinian flag flies at the U.N. for the first time. A panel of journalists joins guest host Melissa Block for analysis of the week's top international news stories.

Friday News Roundup – Domestic

Friday, Oct 02 2015Nine people and a gunman are dead after a shooting at an Oregon community college. Bernie Sanders narrows the fundraising gap with Hillary Clinton in the last quarter. And Congress avoids a government shutdown – for now. A panel of journalists joins guest host Melissa Block of NPR News for analysis of the week's top national news stories.

Steven Lee Myers: “The New Tsar”

Thursday, Oct 01 2015Russian President Putin is widely popular in Russia, despite his ruthless reputation abroad. A former Moscow bureau chief for The New York Times explains how Putin rose from obscurity to become one of the world’s most powerful and enigmatic leaders.

The Debate Over Drug Pricing

Thursday, Oct 01 2015The owner of a drug company has come under fire for dramatically raising the price of medicine that fights deadly infections. And the prices of some heart medications have also spiked. We look at the renewed controversy over high drug prices in the U.S.